V-Bio Ventures and Advent France Biotechnology have co-led a €21m funding round for Belgium-based AgomAb Therapeutics, with participation from Boehringer Ingelheim Venture Fund, Omnes and Pontifax.
Vehicle was registered in Luxembourg in September 2018 and held a first close earlier in the year
Fund will follow the same strategy as its predecessor, Accel London V, which raised €500m
GP sells Dutch petrochemical business BRB to Malaysia-based peer Petronas Chemicals Group
GP acquires a 37.5% stake in the low-calorie drinks brand and typically writes cheques of up to £10m